Clarius Group, LLC Novo Nordisk A S Transaction History

Clarius Group, LLC

  • $1.4 Billion
  • Q3 2024

A detailed history of Clarius Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Clarius Group, LLC holds 13,692 shares of NVO stock, worth $1.21 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
13,692
Previous 14,883 8.0%
Holding current value
$1.21 Million
Previous $2.12 Million 23.26%
% of portfolio
0.12%
Previous 0.15%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024
SELL
$119.07 - $145.42 $141,812 - $173,195
-1,191 Reduced 8.0%
13,692 $1.63 Million
Q2 2024

Jul 11, 2024
SELL
$122.71 - $146.91 $292,540 - $350,233
-2,384 Reduced 13.81%
14,883 $2.12 Million
Q1 2024

Apr 17, 2024
SELL
$102.11 - $135.92 $126,412 - $168,268
-1,238 Reduced 6.69%
17,267 $2.22 Million
Q4 2023

Jan 29, 2024
BUY
$87.78 - $105.45 $8,163 - $9,806
93 Added 0.51%
18,505 $1.91 Million
Q3 2023

Oct 19, 2023
BUY
$90.94 - $199.54 $791,087 - $1.74 Million
8,699 Added 89.56%
18,412 $1.67 Million
Q2 2023

Aug 09, 2023
BUY
$155.98 - $172.65 $6,395 - $7,078
41 Added 0.42%
9,713 $1.57 Million
Q1 2023

Apr 17, 2023
BUY
$132.34 - $159.14 $12,307 - $14,800
93 Added 0.97%
9,672 $1.54 Million
Q4 2022

Jan 25, 2023
SELL
$102.55 - $135.33 $7,998 - $10,555
-78 Reduced 0.81%
9,579 $1.3 Million
Q3 2022

Oct 24, 2022
BUY
$95.28 - $116.93 $205,995 - $252,802
2,162 Added 28.85%
9,657 $962,000
Q2 2022

Aug 10, 2022
BUY
$103.24 - $121.81 $151,246 - $178,451
1,465 Added 24.3%
7,495 $835,000
Q4 2021

Feb 02, 2022
BUY
$95.88 - $117.08 $70,567 - $86,170
736 Added 13.9%
6,030 $675,000
Q3 2021

Oct 18, 2021
BUY
$84.42 - $106.62 $4,474 - $5,650
53 Added 1.01%
5,294 $508,000
Q2 2021

Aug 06, 2021
BUY
$67.66 - $84.76 $55,345 - $69,333
818 Added 18.49%
5,241 $439,000
Q1 2021

Apr 27, 2021
SELL
$67.06 - $75.82 $23,806 - $26,916
-355 Reduced 7.43%
4,423 $298,000
Q4 2020

Jan 15, 2021
BUY
$63.89 - $73.8 $24,789 - $28,634
388 Added 8.84%
4,778 $334,000
Q2 2020

Jul 08, 2020
BUY
$58.54 - $67.94 $7,727 - $8,968
132 Added 3.1%
4,390 $287,000
Q1 2020

Apr 24, 2020
SELL
$49.46 - $64.78 $98 - $129
-2 Reduced 0.05%
4,258 $256,000
Q4 2019

Jan 22, 2020
BUY
$49.86 - $58.26 $4,238 - $4,952
85 Added 2.04%
4,260 $266,000
Q3 2019

Oct 23, 2019
BUY
$47.54 - $53.43 $198,479 - $223,070
4,175 New
4,175 $216,000

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $200B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Clarius Group, LLC Portfolio

Follow Clarius Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email